Metraipolis › archive › dc_6766d953fa03
Oligodendrocyte dysfunction in neurodegenerative diseases: pathological features, underlying mechanisms and therapeutic targeting — Europe PMC PMID:42221032
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42221032
- DOI
- 10.3389/fnagi.2026.1843643
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T16:55:31.885Z
- SHA-256 of the archived text
041da60815318ccd3b424dff27a8960e7d8e74fc6ff7db1837abd0fa1bd437f4- Stable URL of this page
https://metraipolis.com/documento/dc_6766d953fa03
How to cite
Oligodendrocyte dysfunction in neurodegenerative diseases: pathological features, underlying mechanisms and therapeutic targeting — Europe PMC PMID:42221032 — Europe PMC (en), https://europepmc.org/article/MED/42221032 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6766d953fa03 (Metraipolis archive dc_6766d953fa03, sha256 041da60815318ccd3b424dff27a8960e7d8e74fc6ff7db1837abd0fa1bd437f4)
BibTeX
@misc{dc6766d953fa03,
title = {Oligodendrocyte dysfunction in neurodegenerative diseases: pathological features, underlying mechanisms and therapeutic targeting — Europe PMC PMID:42221032},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42221032},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6766d953fa03; sha256 041da60815318ccd3b424dff27a8960e7d8e74fc6ff7db1837abd0fa1bd437f4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42221032. Agents can read the archived copy with the MCP tool read_document.